Page 65 - GPD-2-1
P. 65

Gene & Protein in Disease                                        Pyroptosis-related LncRNAs in pediatric AML




            A                                B                              C















            D                                                  E



















            Figure  7.  Relationship among the risk score, clinical features, clusters, and immune score in AML. (A–C) Risk score in different characteristics:
            (A) clusters; (B) FAB category; (C) age. (D) Results of multivariate Cox regression analysis. (E) Results of univariate Cox regression analysis.

            human T-cell leukemia virus 1 infection, hematopoietic   lncRNAs can be used as potential molecular markers to
            cell lineage, AML, and chronic myeloid leukemia    predict the course and survival status of AML patients .
                                                                                                           [22]
            (Figure 10B).                                      Pyroptosis plays a key role in tumorigenesis and
                                                               tumor progression. At present, studies have found that
            3.8. Establishments of a nomogram and a decision   PR-lncRNAs act as immunotherapy targets or diagnostic
            curve                                              and predictive biomarkers for various cancer types, such
            To further enhance the clinical application value and   as uterine corpus endometrial carcinoma, bladder cancer,
            provide  a  reliable  predictive  model  for  pediatric  AML   colorectal cancer, and so on [23-26] . However, there is still a
            patients,  the  clinical  parameters  and  risk  scores  were   lack of systematic and in-depth studies on the relationship
            combined to build a nomogram (Figure  11A). The    between lncRNAs and the prognosis of AML patients,
            probability of survival in 1, 3, and 5 years can be calculated   especially pediatric AML patients.
            by a nomogram incorporating the score of seven PPR-  In our study, we retrieved 1300 transcriptome data and
            lncRNAs and the clinicopathological parameters; its   the corresponding clinical data from the TARGET database
            calibration curve is shown in  Figure  11B. In addition,   and identified 841 PR-lncRNAs. We, then, classified three
            according to the 1-, 3-, and 5-year DCA curves shown in   clusters according to the count of PR-lncRNAs expression.
            Figure 11C–E, the risk score was the optimal predictor of   WB, BM, and PB were all remarkably lower in cluster 3.
            survival for pediatric AML patients.               Pathways that genes enriched in better prognostic clusters

            4. Discussion                                      (cluster 3) were mainly important immune-related
                                                               signaling pathways, including B-cell and T-cell receptor
            With the rapid advancements in bioinformatics, predicting   signaling  pathways,  NOD-like  and  Toll-like  receptor
            the prognosis of pediatric AML patients by assessing the   signaling pathways, and Fc epsilon RI signaling pathway,
            risk level of pediatric AML at the molecular level has   which were derived from GSEA. Comparing the better and
            become a  reality.  The regulatory mechanisms involved   the poorer prognostic clusters (cluster 3 and cluster 1), there
            in the lncRNA-mediated regulation of AML suggest that   were significantly different proportions in nine out of 22


            Volume 2 Issue 1 (2023)                         10                     https://doi.org/10.36922/gpd.v2i1.230
   60   61   62   63   64   65   66   67   68   69   70